Cardiovascular Clinical Consult

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure With Preserved Ejection Fraction

Redefining Optimal Therapy for Patients with Heart Failure with Reduced Ejection Fraction: Integrating New Guidelines, Emerging Agents, and Pharmacist-led Transitions of Care

Targeting the Clinical Course of Hypertrophic Cardiomyopathy: Keeping a Beat on New and Emerging Therapies

The Impact of PCSK9 Modulation on Cardiovascular Outcomes: Recent Advances and the Managed Care Implications

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

Risks and Liabilities in Pharmacy Practice

The Management of HFrEF With New and Emerging Mechanisms of Action: Updates for Pharmacists

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

Introduction to Anticoagulation and the Appropriate Patient

The Treatment Landscape and a Review of Approved DOAC Agents

The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings

Understanding the Challenges of Homozygous Familial Hypercholesterolemia

Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia

Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management

Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction

Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fraction

Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and Improving Adherence

Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration